{"doi":"10.1016/j.ejca.2023.03.015","title":"Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician’s Choice","abstract":"PURPOSE: Lenvatinib and pembrolizumab (LEN+PEMBRO) demonstrated clinically meaningful and statistically significant improvements in efficacy versus treatment of physician's choice (TPC) in patients with advanced endometrial cancer (aEC) in the phase 3 Study 309/KEYNOTE-775. Health-related quality-of-life (HRQoL) is reported. PATIENTS AND METHODS: [weekly, 3 weeks on/1 week off]). Impact of treatment on HRQoL assessed by the global health status/quality of life (GHS/QoL) score of the European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire (EORTC QLQ-C30) was a secondary objective; other scales of the Quality-of-Life Questionnaire (QLQ-C30), EORTC QLQ-Endometrial, 24 questions (EORTC QLQ-EN24), and EuroQoL 5 dimensions, 5 levels (EQ-5D-5L) were exploratory objectives. HRQoL was assessed on day 1 of each cycle. Completion/compliance, change from baseline, time to first and definitive deterioration were assessed. No multiplicity adjustments were applied for HRQoL endpoints. RESULTS: The latest timepoint at which the predefined rates of completion (≥60%) and compliance (≥80%) were met was week 12. HRQoL at week 12 between treatment groups was generally similar. Time to first deterioration symptom scales favoured LEN+PEMBRO for QLQ-C30 dyspnoea, and QLQ-EN24 for poor body image, tingling/numbness, and hair loss; and TPC was favoured for QLQ-C30 pain, appetite loss, and diarrhoea, and QLQ-EN24 muscular pain. While the QLQ-C30 physical functional scale favoured TPC, other functional scales were generally similar between arms. Time to definitive deterioration favoured LEN+PEMBRO on most scales. CONCLUSION: HRQoL data from Study 309/KEYNOTE-775, with previously published efficacy and safety results, indicate that LEN+PEMBRO has an overall favourable benefit/risk profile versus TPC for the treatment of patients with aEC. CLINICALTRIALS: GOV: NCT03517449.","journal":"European Journal of Cancer","year":2023,"id":338197,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":17,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.7612,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":50716,"name":"Nicoletta Colombo","orcid":"0000-0003-2225-715X","position":1,"is_corresponding":false},{"id":691181,"name":"Antonio Casado","orcid":"0000-0002-8200-3306","position":2,"is_corresponding":false},{"id":256628,"name":"Alessandro D. Santin","orcid":"0000-0003-4724-9738","position":3,"is_corresponding":false},{"id":1070603,"name":"Émeline Colomba","orcid":"0000-0002-3631-316X","position":4,"is_corresponding":false},{"id":66131,"name":"David S. Miller","orcid":"0000-0002-8215-5887","position":5,"is_corresponding":false},{"id":346845,"name":"Keiichi Fujiwara","orcid":"0000-0002-7388-0243","position":6,"is_corresponding":false},{"id":258141,"name":"Sandro Pignata","orcid":"0000-0002-8836-2633","position":7,"is_corresponding":false},{"id":33631,"name":"Sally Baron‐Hay","orcid":"0000-0002-9748-1458","position":8,"is_corresponding":false},{"id":1071140,"name":"Isabelle Laure Ray-Coquard","orcid":null,"position":9,"is_corresponding":false},{"id":857636,"name":"Ronnie Shapira‐Frommer","orcid":"0000-0001-6170-080X","position":10,"is_corresponding":false},{"id":1070604,"name":"Yong Man Kim","orcid":"0000-0002-4222-3400","position":11,"is_corresponding":false},{"id":850776,"name":"Mary McCormack","orcid":"0000-0002-8429-5744","position":12,"is_corresponding":false},{"id":1071141,"name":"Rachid Massaad","orcid":null,"position":13,"is_corresponding":false},{"id":1070605,"name":"Allison Martin Nguyen","orcid":"0000-0002-6385-5570","position":14,"is_corresponding":false},{"id":1070606,"name":"Qi Zhao","orcid":"0000-0002-8683-6145","position":15,"is_corresponding":false},{"id":479307,"name":"Jodi A. McKenzie","orcid":"0000-0002-6345-1218","position":16,"is_corresponding":false},{"id":1070607,"name":"Vimalanand S. Prabhu","orcid":"0000-0003-1358-8846","position":17,"is_corresponding":false},{"id":235765,"name":"Vicky Makker","orcid":"0000-0001-9793-7614","position":18,"is_corresponding":false},{"id":406831,"name":"Domenica Lorusso","orcid":"0000-0003-0981-0598","position":0,"is_corresponding":true}],"reference_count":25,"raw_metadata":null,"created_at":"2026-07-19T01:10:35.973121Z","pmid":"37086595","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}